Comparison of allogeneic vs autologous bone marrow?derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Comparison of allogeneic vs autologous bone marrow?derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012 Dec 12; 308(22):2369-79.

View in: PubMed

subject areas

Aged
Bone Marrow Transplantation
Cardiomyopathies
Female
HLA Antigens
Humans
Male
Mesenchymal Stem Cell Transplantation
Middle Aged
Myocardial Ischemia
Quality of Life
Transplantation, Autologous
Transplantation, Homologous
Treatment Outcome
Ventricular Dysfunction, Left
Ventricular Remodeling

authors with profiles

Melissa Tracy